Pharmaceuticals News and Research

RSS

SureGene collaborates with Medco Health Solutions to conduct REST study

SureGene, LLC and the Medco Research Institute, LLC, a wholly-owned subsidiary of Medco Health Solutions, Inc., today announced that they have entered into a novel investigative research collaboration to evaluate whether variation in genetic biomarkers previously identified by SureGene can help predict drug response for widely prescribed antipsychotic drugs in patients with serious mental illness.

25 Aug 2010

FDA grants Fast Track Designation to Celsion's ThermoDox for liver cancer treamtment

Celsion Corporation, a leading oncology drug development company, today announced that the U.S. Food and Drug Administration has designated the HEAT Study of its investigational drug, ThermoDox, in combination with radiofrequency ablation, as a Fast Track Development Program.

25 Aug 2010

Advanced Life Sciences seeks government funding for development of Restanza antibiotic

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced plans to seek additional government funding for development of its novel, once-daily antibiotic, Restanza.

25 Aug 2010

BioAlliance Pharma launches Oravig drug in the U.S. market

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announces the launch in the United States of Oravig® (known as Loramyc® in Europe) for the treatment of oropharyngeal candidiasis (OPC) in adults by its commercial partner, Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc..

25 Aug 2010

Dyadic International completes private placement of secured promissory notes

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced that it has completed a private placement of $3,000,000 in convertible subordinated secured promissory notes (the "Notes") with two investors.

25 Aug 2010

Study examines movement of pediatric drug testing outside the U.S.

"A law intended to speed up development of new drugs for U.S. kids has ended up financing clinical trials in poor countries, where the medicines might never become available," suggest the authors of a study published online Monday in the journal Pediatrics, Reuters reports (Joelving, 8/23).

25 Aug 2010

BioScale installs ViBE analytical tool at Massachusetts-based pharmaceutical company

BioScale Inc., an innovative life science company that develops, manufactures and promotes novel analytical tools enabling advancements in protein research, today announced the first shipment and installation of the ViBE™ Protein Analysis Workstation at a major Massachusetts-based pharmaceutical company.

25 Aug 2010

Access Pharmaceuticals to highlight Cobalamin nanotechnology at ACS National Meeting

ACCESS PHARMACEUTICALS, INC.,a biopharmaceutical company specializing in products for cancer and supportive care, announced that its Director of Chemistry and Quality, Dr. Ric Zarzycki will give an invited presentation today on the Company's Cobalamin nanoparticle technology at a thought-leadership symposium being held at the American Chemical Society's ("ACS") 240th National Meeting & Exposition, at Boston Convention and Exhibition Center in Boston, Massachusetts, August 22-26, 2010.

25 Aug 2010

DSM Biomedical signs new licensing agreements with global medical device manufacturers

DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the company has entered into six multi-year licensing agreements with global medical device manufacturers in the Orthopedic, Cardiovascular, Vascular and Urology fields in this year alone.

25 Aug 2010

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

Alnylam Pharmaceuticals, Inc.,a leading RNAi therapeutics company, announced today that it will make a total of 16 oral presentations at the American Chemical Society (ACS) Fall 2010 240th National Meeting & Exposition being held in Boston, Mass. from August 22-26, 2010.

24 Aug 2010

3SBio and Isotechnika enter strategic agreement for voclosporin in China

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products and Isotechnika Pharma Inc., a biopharmaceutical company focused on the discovery and development of immune modulating therapeutics, today announced the signing of a development and commercialization agreement for voclosporin.

24 Aug 2010

First patient treated in Synta Pharmaceuticals' clinical trial of STA-9090

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination with docetaxel for the treatment of advanced solid tumor malignancies.

24 Aug 2010

Consumers economizing on healthcare in ways that might be dangerous: Poll

More than two-thirds (69%) of Americans currently taking a prescription drug say drug makers have too much influence on doctors' prescribing decisions and half say that doctors are too eager to prescribe a drug when other non-drug options are available for managing a condition. Those are just some of the concerns raised by Americans in a new prescription drug poll by the Consumer Reports National Research Center. More information about the poll is available online at www.consumerreportsenespanol.org.

24 Aug 2010

Raptor Pharmaceutical updates on cysteamine bitartrate Phase 3 clinical trial in cystinosis patients

Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

24 Aug 2010

Belgium GZA Hospital Group implements AeroScout's Temperature Monitoring solution

AeroScout, the leading provider of Unified Asset Visibility for the healthcare industry, today announced that the GasthuisZusters Antwerpen (GZA) Hospital Group in Belgium has implemented AeroScout's Temperature Monitoring solution across its three hospitals. GZA Hospital Group is using the Wi-Fi RFID solution to monitor and manage the temperature in refrigerators that contain critical items, such as pharmaceuticals and blood.

24 Aug 2010

OSDD program aims to develop new drug for tuberculosis

An unlikely effort is underway to lift the veil of nearly-total secrecy that has surrounded the process of developing new prescription drugs for the last century, scientists said today at the 240th National Meeting of the American Chemical Society (ACS). The upheaval in traditional practice would make key data available to college students, university professors, and others in an open, collective process.

24 Aug 2010

Boryung Pharmaceutical implements Cegedim Dendrite's Mobile Intelligence CRM solution

Cegedim Dendrite, the world's leading provider of Life Sciences-specific customer relationship management (CRM) solutions, announced today that Boryung Pharmaceutical Co., Ltd., has implemented Cegedim Dendrite's Mobile Intelligence™ CRM solution. Boryung Pharmaceutical is one of Korea's top 10 domestic pharmaceutical companies, and Cegedim Dendrite currently serves 14 of the industry's top-grossing companies in Korea.

24 Aug 2010

Medivir appoints Daewoong as South Korean distributor for Xerclear

Medivir AB today announced it has appointed Daewoong Pharmaceutical Co. Ltd. as its exclusive distributor for Xerclear™ in South Korea. Under the terms of the agreement, Daewoong will be responsible for obtaining the regulatory approvals, and for marketing, sales and distribution of Medivir's cold sore product in the territory. In consideration of the rights granted to Daewoong, Medivir will receive upfront and milestone payments and royalties on sales according to a profit sharing scheme.

24 Aug 2010

Spaulding Clinical becomes world’s largest provider for Mortara Surveyor telemetry-monitoring capability

Spaulding Clinical Research, a Phase 1 Clinical Pharmacology Research Unit and Core ECG Lab announced today that renovation of the clinic's second floor, which was completed on Aug. 20, has made Spaulding Clinical the largest provider of Mortara Surveyor telemetry-monitoring capability in the clinical research world.

24 Aug 2010

AP reports on efforts to monitor authenticity of antimalarials, other drugs in Africa

The Associated Press reports on a recent effort to use text messages to track the authenticity of antimalarials in Africa, where "more than 30 percent of malaria medicines are estimated to be fake."

24 Aug 2010

Pharmaceuticals News and Research

SureGene collaborates with Medco Health Solutions to conduct REST study

FDA grants Fast Track Designation to Celsion's ThermoDox for liver cancer treamtment

Advanced Life Sciences seeks government funding for development of Restanza antibiotic

BioAlliance Pharma launches Oravig drug in the U.S. market

Dyadic International completes private placement of secured promissory notes

Study examines movement of pediatric drug testing outside the U.S.

BioScale installs ViBE analytical tool at Massachusetts-based pharmaceutical company

Access Pharmaceuticals to highlight Cobalamin nanotechnology at ACS National Meeting

DSM Biomedical signs new licensing agreements with global medical device manufacturers

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

3SBio and Isotechnika enter strategic agreement for voclosporin in China

First patient treated in Synta Pharmaceuticals' clinical trial of STA-9090

Consumers economizing on healthcare in ways that might be dangerous: Poll

Raptor Pharmaceutical updates on cysteamine bitartrate Phase 3 clinical trial in cystinosis patients

Belgium GZA Hospital Group implements AeroScout's Temperature Monitoring solution

OSDD program aims to develop new drug for tuberculosis

Boryung Pharmaceutical implements Cegedim Dendrite's Mobile Intelligence CRM solution

Medivir appoints Daewoong as South Korean distributor for Xerclear

Spaulding Clinical becomes world’s largest provider for Mortara Surveyor telemetry-monitoring capability

AP reports on efforts to monitor authenticity of antimalarials, other drugs in Africa

Industry Focus - Biopharma eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence